Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada
Abstract Background: With legal access to medical cannabis in Canada since 2001, there is a need to fully characterize its…
Abstract Background: With legal access to medical cannabis in Canada since 2001, there is a need to fully characterize its…
Abstract In light of the recent changes in the legal status of cannabis in Canada, the understanding of the potential…
Abstract Background: The opioid overdose epidemic in Canada and the United States has become a public health crisis – with…
Abstract Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (Covid-19), has been a serious threat…
Abstract Symptomatic management of Parkinson’s disease (PD) is complex and many symptoms, especially non-motor symptoms, are not effectively addressed with…
Abstract Lung cancer is the leading cause of global cancer incidence and mortality, accounting for an estimated 2 million diagnoses…
Abstract Posttraumatische Belastungsstörung und Substanzkonsumstörungen treten im medizinischen Versorgungssystem häufig koexistent auf. Ihre Komorbidität geht mit schwerwiegenderen akuten klinischen Symptombildern,…
Abstract Fundamentos: Las encuestas epidemiológicas son las fuentes básicas de información sobre el consumo de drogas, aunque presentan algunas limitaciones…
Abstract Background: In 2016, the Australian federal government passed legislation enabling a range of cannabis-based products to be prescribed to…
Abstract À l’heure où l’usage médical de la plante « cannabis dit thérapeutique » est pratiquement acté dans notre pays,…